However, the application of PSA to population-based PrCa screening to provide confirmatory diagnosis with biopsy to identify false negative cases from a large proportion of test negative cases (PSA below cutoff level) is not feasible due to the invasiveness of biopsy and the enormous costs involved. Here, KLK3 is linked to pure red-cell aplasia.